Literature DB >> 20618884

Proliferative, structural and molecular features of the Mdx mouse prostate.

Leslie C Pinto1, Wagner J Fávaro, Valéria H A Cagnon.   

Abstract

The prostate is fundamental to the male reproductive process, and the stroma-epithelium interaction has an important role in prostate maintenance. Studies suggest that dystroglycan (DG) plays a role in cancer development in various organs. Thus, the aims of this work were to characterize morphological and proliferative features of the prostatic stroma and epithelium of mdx mice; to verify the immunolocalization of the α and β DG, IGF-1 and laminin α3 receptors; and to relate those structural and molecular events to prostate pathogenesis and to verify the viability of this experimental model in prostate studies. Thirty male mice (mdx and C57BL10/Uni) were divided into control and mdx groups. Samples from the ventral prostate were collected for immunological, Western Blotting, transmission electron microscopy and morphometric analyses. Oestradiol and testosterone measurements were verified. The results showed diminished testosterone and increased oestradiol levels in the mdx group. Atrophied cells and hypertrophied stroma were seen in the mdx mice. Weak α and β DG and laminin α3 immunolocalization was demonstrated in the mdx group. Intense insulin-like growth factor receptor α-1 (IGFRα-1) localization was identified in the mdx animals. Thus, mdx animals showed changes in molecular and structural integrity and proliferation signals, leading to glandular homoeostasis imbalance, and compromise of prostate function. Also, the steroid hormone imbalance and the increased IGF-1 receptor level detected in mdx mice could be considered as a crucial factor in the pathogenesis of prostatic disorders.
© 2010 The Authors. Journal compilation © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618884      PMCID: PMC3003838          DOI: 10.1111/j.1365-2613.2010.00722.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  94 in total

1.  Experimental alcoholism and pathogenesis of prostatic diseases in UChB rats.

Authors:  Eduardo Marcelo Cândido; César Alexandre Fabrega Carvalho; Francisco Eduardo Martinez; Valéria Helena Alves Cagnon
Journal:  Cell Biol Int       Date:  2006-11-19       Impact factor: 3.612

2.  17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.

Authors:  Giuseppe Pandini; Marco Genua; Francesco Frasca; Sebastiano Squatrito; Riccardo Vigneri; Antonino Belfiore
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

3.  Hormonal profile of diabetic men and the potential link to prostate cancer.

Authors:  Jocelyn S Kasper; Yan Liu; Michael N Pollak; Nader Rifai; Edward Giovannucci
Journal:  Cancer Causes Control       Date:  2008-03-14       Impact factor: 2.506

4.  Remodeling of rat ventral prostate after castration involves heparanase-1.

Authors:  Taize M Augusto; Sérgio L Felisbino; Hernandes F Carvalho
Journal:  Cell Tissue Res       Date:  2008-02-16       Impact factor: 5.249

5.  The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy.

Authors:  L A Begley; S Kasina; J MacDonald; J A Macoska
Journal:  Cytokine       Date:  2008-06-24       Impact factor: 3.861

6.  Ultrastructural and proliferative features of the ventral lobe of the prostate in non-obese diabetic mice (NOD) following androgen and estrogen replacement associated to insulin therapy.

Authors:  W J Fávaro; C R Padovani; V H A Cagnon
Journal:  Tissue Cell       Date:  2008-11-18       Impact factor: 2.466

Review 7.  Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma.

Authors:  A J Lyons; J Jones
Journal:  Int J Oral Maxillofac Surg       Date:  2007-07-23       Impact factor: 2.789

8.  Effects of streptozotocin (STZ)-induced diabetes and insulin replacement on rat ventral prostate.

Authors:  E Suthagar; S Soudamani; S Yuvaraj; A Ismail Khan; M M Aruldhas; K Balasubramanian
Journal:  Biomed Pharmacother       Date:  2008-02-11       Impact factor: 6.529

9.  Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.

Authors:  Alessandro Sgambato; Andrea Camerini; Domenico Amoroso; Giannicola Genovese; Filomena De Luca; Massimo Cecchi; Mario Migaldi; Alessandro Rettino; Chiara Valsuani; Gianna Tartarelli; Sara Donati; Olimpia Siclari; Giulio Rossi; Achille Cittadini
Journal:  Cancer Biol Ther       Date:  2007-09-05       Impact factor: 4.742

10.  Expression of beta-dystroglycan is reduced or absent in many human carcinomas.

Authors:  S S Cross; J Lippitt; A Mitchell; F Hollingsbury; S P Balasubramanian; M W R Reed; C Eaton; J W Catto; F Hamdy; S J Winder
Journal:  Histopathology       Date:  2008-11       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.